Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy

World Journal of Gastroenterology

Volumn 20, Issue 24, 2014, Pages 7635-7643

  Sagnelli, Evangelista ^a   Sagnelli, Caterina ^a   Pisaturo, Mariantonietta ^a   Macera, Margherita ^a   Coppola, Nicola ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Acute hepatitis B; Acute hepatitis delta; Chronic viral hepatitis; Hepatitis B virus epidemiology; Hepatitis delta virus epidemiology

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ARTICLE; BIRTH RATE; DELTA AGENT HEPATITIS; DISEASE ASSOCIATION; ENDEMIC DISEASE; EXPOSURE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; ITALY; MORBIDITY; PREVALENCE; RISK FACTOR; UNSAFE SEX; VACCINATION; VIRUS TRANSMISSION; ACUTE DISEASE; HEPATITIS B, CHRONIC; HEPATITIS D; HEPATITIS D, CHRONIC; TIME; TRANSMISSION;

ACUTE DISEASE; HEPATITIS B; HEPATITIS B, CHRONIC; HEPATITIS D; HEPATITIS D, CHRONIC; HUMANS; ITALY; RISK FACTORS; TIME FACTORS;

EID: 84903123838     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i24.7635     Document Type: Article

References (75)

1. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005; 34 Suppl 1: S1-S3 [PMID: 16461208 DOI: 10.1016/S1386-6532(05)00384-7]
2. European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009; 50: 227-242 [PMID: 19054588 DOI: 10.1016/j.jhep.2008.10.001]
3. Murata K, Sugimoto K, Shiraki K, Nakano T. Relative predictive factors for hepatocellular carcinoma after HBeAg seroconversion in HBV infection. World J Gastroenterol 2005; 11: 6848-6852 [PMID: 16425395]
4. Ou DP, Yang LY, Huang GW, Tao YM, Ding X, Chang ZG. Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV. World J Gastroenterol 2005; 11: 2061-2066 [PMID: 15810069]
5. Borgia G, Gentile I. Treating chronic hepatitis B: today and tomorrow. Curr Med Chem 2006; 13: 2839-2855 [PMID: 17073632 DOI: 10.2174/092986706778521995]
6. Cao GW. Clinical relevance and public health significance of hepatitis B virus genomic variations. World J Gastroenterol 2009; 15: 5761-5769 [PMID: 19998495]
7. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009; 373: 582-592 [PMID: 19217993 DOI: 10.1016/S0140-6736(09)60207-5]
8. Wasley A, Grytdal S, Gallagher K. Surveillance for acute viral hepatitis--United States, 2006. MMWR Surveill Summ 2008; 57: 1-24 [PMID: 18354374]
9. Borgia G, Carleo MA, Gaeta GB, Gentile I. Hepatitis B in pregnancy. World J Gastroenterol 2012; 18: 4677-4683 [PMID: 23002336 DOI: 10.3748/wjg.v18.i34.4677]
10. Kao JH. Role of viral factors in the natural course and therapy of chronic hepatitis B. Hepatol Int 2007; 1: 415-430 [PMID: 19669337 DOI: 10.1007/s12072-007-9033-2]
11. Barker LF, Chisari FV, McGrath PP, Dalgard DW, Kirschstein RL, Almeida JD, Edington TS, Sharp DG, Peterson MR. Transmission of type B viral hepatitis to chimpanzees. J Infect Dis 1973; 127: 648-662 [PMID: 4574998]
12. Coppola N, Masiello A, Tonziello G, Pisapia R, Pisaturo M, Sagnelli C, Messina V, Iodice V, Sagnelli E. Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area. J Viral Hepat 2010; 17: 493-500 [PMID: 19780943 DOI: 10.1111/j.1365-2893.2009.01201.x]
13. Coppola N, Tonziello G, Colombatto P, Pisaturo M, Messina V, Moriconi F, Alessio L, Sagnelli C, Cavallone D, Brunetto M, Sagnelli E. Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B. J Infect 2013; 67: 322-328 [PMID: 23796869]
14. Crovari P. Epidemiology of viral hepatitis B in Italy. Vaccine 1995; 13 Suppl 1: S26-S30 [PMID: 7571823]
15. Rizzetto M, Canese MG, Aricò S, Crivelli O, Trepo C, Bonino F, Verme G. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977; 18: 997-1003 [PMID: 75123]
16. Romanò L, Paladini S, Tagliacarne C, Zappa A, Zanetti AR. The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination. Vaccine 2009; 27: 3439-3442 [PMID: 19200848 DOI: 10.1016/j.vaccine.2009.01.056]
17. Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol 2010; 7: 31-40 [PMID: 20051970 DOI: 10.1038/nrgastro.2009.205]
18. Stroffolini T, Almasio PL, Sagnelli E, Mele A, Gaeta GB. Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study. J Med Virol 2009; 81: 1999-2006 [PMID: 19856477 DOI: 10.1002/jmv.21643]
19. Alvarado-Mora MV, Locarnini S, Rizzetto M, Pinho JR. An update on HDV: virology, pathogenesis and treatment. Antivir Ther 2013; 18: 541-548 [PMID: 23792471 DOI: 10.3851/ IMP2598]
20. Dunford L, Carr MJ, Dean J, Nguyen LT, Ta Thi TH, Nguyen BT, Connell J, Coughlan S, Nguyen HT, Hall WW, Thi LA. A multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet Nam. PLoS One 2012; 7: e39027 [PMID: 22720022 DOI: 10.1371/journal.pone.0039027]
21. Noureddin M, Gish R. Hepatitis delta: epidemiology, diagnosis and management 36 years after discovery. Curr Gastroenterol Rep 2014; 16: 365 [PMID: 24293018 DOI: 10.1007/ s11894-013-0365-x]
22. Sagnelli E, Stroffolini T, Mele A, Imparato M, Almasio PL. Chronic hepatitis B in Italy: new features of an old disease-approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection. Clin Infect Dis 2008; 46: 110-113 [PMID: 18171224 DOI: 10.1086/524074]
23. Sagnelli E, Stroffolini T, Ascione A, Bonino F, Chiaramonte M, Colombo M, Craxi A, Giusti G, Manghisi OG, Pastore G. The epidemiology of hepatitis delta infection in Italy. Promoting Group. J Hepatol 1992; 15: 211-215 [PMID: 1506640 DOI: 10.1016/0168-8278(92)90038-Q]
24. Mele A, Rosmini F, Zampieri A, Gill ON. Integrated epidemiological system for acute viral hepatitis in Italy (SEIEVA): description and preliminary results. Eur J Epidemiol 1986; 2: 300-304 [PMID: 3100322]
25. Spada E, Mele A, Mariano A, Zuccaro O, Tosti ME. Risk factors for and incidence of acute hepatitis C after the achievement of blood supply safety in Italy: results from the national surveillance system. J Med Virol 2013; 85: 433-440 [PMID: 23280786 DOI: 10.1002/jmv.23485]
26. McMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP, Maynard JE. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151: 599-603 [PMID: 3973412]
27. Giusti G, Galanti B, Gaeta GB. Epidemiology of viral hepatitis in Italy. Boll Ist Sieroter Milan 1980; 59: 571-580 [PMID: 6786301]
28. Gasparini R, Coppola R, Marensi R, Crovari P. L'Epatite virale nel comune di Genova. Giorn. Ig. Med Prev 1980; 21: 161-190
29. Stroffolini T. The changing pattern of hepatitis B virus infection over the past three decades in Italy. Dig Liver Dis 2005; 37: 622-627 [PMID: 15996630 DOI: 10.1016/j.dld.2005.02.010]
30. Zanetti AR, Tanzi E, Romanò L, Grappasonni I. Vaccination against hepatitis B: the Italian strategy. Vaccine 1993; 11: 521-524 [PMID: 8488702 DOI: 10.1016/0264-410X(93)90222-J]
31. Piazza M, Da Villa G, Picciotto L, Abrescia N, Guadagnino V, Memoli AM, Vegnente A, Iorio R, Cimmino L. Mass vaccination against hepatitis B in infants in Italy. Lancet 1988; 2: 1132 [PMID: 2903337]
32. Zanetti AR, Mariano A, Romanò L, D'Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, Parlato A, Zamparo E, Zotti C, Stroffolini T, Mele A. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005; 366: 1379-1384 [PMID: 16226616 DOI: 10.1016/S01406736(05)67568-X]
33. Stroffolini T, Mele A, Tosti ME, Gallo G, Balocchini E, Ragni P, Santonastasi F, Marzolini A, Ciccozzi M, Moiraghi A. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol 2000; 33: 980-985 [PMID: 11131462 DOI: 10.1016/ S0168-8278(00)80132-4]
34. Bialek SR, Bower WA, Mottram K, Purchase D, Nakano T, Nainan O, Williams IT, Bell BP. Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users. J Urban Health 2005; 82: 468-478 [PMID: 16049202]
35. Mele A, Catapano R, Ferrigno L, Marzolini A, Stazi MA, Martelli A, Pasquini P. Sistema Epidemiologico Integrato dell'Epatite Virale Acuta. Rapporto. annuale 1991. Roma: Rapporti Istituto Superiore di sanità, 1993; N° 16
36. di Sanità IS. Sistema Epidemiologico Integrato Epatite Virale Acuta. Roma: Istituto Superiore di Sanità. Available from: URL: http://www.iss.it/seieva/. Last visited Dec 15, 2011
37. Spada E, Mele A, Ciccozzi M, Tosti ME, Bianco E, Szklo A, Ragni P, Gallo G, Balocchini E, Sangalli M, Lopalco PL, Moiraghi A, Stroffolini T. Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy. Dig Liver Dis 2001; 33: 778-784 [PMID: 11838613 DOI: 10.1016/S1590-8658(01)80695-2]
38. Mele A, Tosti ME, Mariano A, Pizzuti R, Ferro A, Borrini B, Zotti C, Lopalco P, Curtale F, Balocchini E, Spada E. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis 2008; 46: 868-875 [PMID: 18269332 DOI: 10.1086/528687]
39. Mele A, Spada E, Sagliocca L, Ragni P, Tosti ME, Gallo G, Moiraghi A, Balocchini E, Sangalli M, Lopalco PL, Stroffoli T. Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive procedures: results from the hepatitis surveillance system in Italy. J Hepatol 2001; 35: 284-289 [PMID: 11580153 DOI: 10.1016/ S0168-8278(01)00111-8]
40. Mariano A, Mele A, Tosti ME, Parlato A, Gallo G, Ragni P, Zotti C, Lopalco P, Pompa MG, Graziani G, Stroffolini T. Role of beauty treatment in the spread of parenterally transmitted hepatitis viruses in Italy. J Med Virol 2004; 74: 216-220 [PMID: 15332269 DOI: 10.1002/jmv.20182]
41. Baxa DM, Thekdi AD, Golembieski A, Krishnan PV, Sharif O, Kizy A, Shetron-Rama L, Jovanovich J, Chappell BJ, Snow-Lampart A, Borroto-Esoda K, Gordon SC. Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States. J Hepatol 2013; 58: 212-216 [PMID: 23022497 DOI: 10.1016/ j.jhep.2012.09.014]
42. Coppola N, Loquercio G, Tonziello G, Azzaro R, Pisaturo M, Di Costanzo G, Starace M, Pasquale G, Cacciapuoti C, Petruzziello A. HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient. J Clin Virol 2013; 58: 315-317 [PMID: 23856167 DOI: 10.1016/j.jcv.2013.06.020]
43. Farci P. Delta hepatitis: an update. J Hepatol 2003; 39 Suppl 1: S212-S219 [PMID: 14708706]
44. Farci P, Niro GA. Clinical features of hepatitis D. Semin Liver Dis 2012; 32: 228-236 [PMID: 22932971 DOI: 10.1055/ s-0032-132362]
45. Wedemeyer H. Hepatitis D revival. Liver Int 2011; 31 Suppl 1: 140-144 [PMID: 21205152 DOI: 10.1111/j.1478-3231.2010.02408. x]
46. Smedile A, Dentico P, Zanetti A, Sagnelli E, Nordenfelt E, Actis GC, Rizzetto M. Infection with the delta agent in chronic HBsAg carriers. Gastroenterology 1981; 81: 992-997 [PMID: 7286594]
47. Sagnelli E, Stroffolini T, Ascione A, Chiaramonte M, Craxì A, Giusti G, Piccinino F. Decrease in HDV endemicity in Italy. J Hepatol 1997; 26: 20-24 [PMID: 9148012 DOI: 10.1016/ S0168-8278(97)80004-9]
48. Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S, Sagnelli E, Brunetto MR, Rizzetto M. Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology 2000; 32: 824-827 [PMID: 11003629]
49. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007; 45: 1056-1075 [PMID: 17393513]
50. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-539 [PMID: 17256718]
51. Hadziyannis SJ, Vassilopoulos D. Hepatitis B e antigennegative chronic hepatitis B. Hepatology 2001; 34: 617-624 [PMID: 11584355]
52. Martinot-Peignoux M, Boyer N, Colombat M, Akremi R, Pham BN, Ollivier S, Castelnau C, Valla D, Degott C, Marcellin P. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 2002; 36: 543-546 [PMID: 11943427]
53. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxì A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky JM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trépo C, Villa E, Will H, Zanetti AR, Zoulim F. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008; 49: 652-657 [PMID: 18715666 DOI: 10.1016/j.jhep.2008.07.014]
54. Coppola N, Gentile I, Pasquale G, Buonomo AR, Capoluongo N, D'Armiento M, Borgia G, Sagnelli E. Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C. Ann Hepatol 2013; 13: 20-26 [PMID: 24378262]
55. Coppola N, Tonziello G, Pisaturo M, Messina V, Guastafierro S, Fiore M, Iodice V, Sagnelli C, Stanzione M, Capoluongo N, Pasquale G, Sagnelli E. Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings. J Med Virol 2011; 83: 1909-1916 [PMID: 21915865 DOI: 10.1002/jmv.22199]
56. Dardanoni L, Mele A, Polizzi MC. Epidemiology of hepatitis B in Italy. Ann Ist Super Sanita 1987; 24: 235-243 [PMID: 3453605]
57. Stroffolini T. Epidemiologia dell'Epatite B in Italia. In: La vaccinazione contro l'Epatite da virus B: una scelta prioritaria di politica sanitaria ed economica. Milan: Franco Angelini, 1990: pp. 17-28
58. Giusti G, Galanti B, Gaeta GB, Piccinino F, Ruggiero G. HBsAg carriers among blood donors in Italy; a retrospective survey of data from 189 blood banks. Hepatogastroenterology 1981; 28: 96-98 [PMID: 7216155]
59. Pasquini P, Kahn HA, Pileggi D, Panà A, Terzi J, Guzzanti E. Prevalence of hepatitis B markers in Italy. Am J Epidemiol 1983; 118: 699-709 [PMID: 6637996]
60. Da Villa G, Romanò L, Sepe A, Iorio R, Paribello N, Zappa A, Zanetti AR. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of antiHBs antibody in two cohorts of vaccinated individuals. Vaccine 2007; 25: 3133-3136 [PMID: 17280750 DOI: 10.1016/ j.vaccine.2007.01.044]
61. Crovari P, Gay A, Bertorello C, Furfaro M, De Flora S. Epidemiological survey of hepatitis B virus infections in various groups of population. Boll Ist Sieroter Milan 1979; 58: 25-40 [PMID: 399732]
62. Sagnelli E, Stroffolini T, Mele A, Almasio P, Coppola N, Ferrigno L, Scolastico C, Onofrio M, Imparato M, Filippini P. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases. J Med Virol 2005; 75: 522-527 [PMID: 15714480 DOI: 10.1002/ jmv.20313]
63. Piccinino F, Manzillo G, Sagnelli E, Balestrieri G, Maio G. Familial clustering of hepatitis B antigen and liver diseases in families with a high incidence of viral hepatitis. Infection 1975; 3: 99-104 [PMID: 1184196 DOI: 10.1007/BF01641050]
64. D'Argenio P, Esposito D, Mele A, Ortolani G, Adamo B, Rapicetta M, Forte P, Pisani A, Soldo L, Sarrecchia B. Decline in the exposure to hepatitis A and B infections in children in Naples, Italy. Public Health 1989; 103: 385-389 [PMID: 2798751]
65. Stroffolini T, Bianco E, Szklo A, Bernacchia R, Bove C, Colucci M, Cristina Coppola R, D'Argenio P, Lopalco P, Parlato A, Ragni P, Simonetti A, Zotti C, Mele A. Factors affecting the compliance of the antenatal hepatitis B screening programme in Italy. Vaccine 2003; 21: 1246-1249 [PMID: 12559805 DOI: 10.1016/S0264-410X(02)00439-5]
66. D'Amelio R, Stroffolini T, Nisini R, Matricardi PM, Rapicetta M, Spada E, Napoli A, Pasquini P. Incidence of hepatitis B virus infection among an Italian military population: evidence of low infection spread. Eur J Epidemiol 1994; 10: 105-107 [PMID: 7957780 DOI: 10.1007/BF01717462]
67. Giusti G, Sagnelli E, Gallo C, Piccinino F, Galanti B, Gaeta GB. The etiology of chronic hepatitis in Italy: a multicenter study. Hepatogastroenterology 1994; 41: 397-400 [PMID: 7959581]
68. Stroffolini T, Sagnelli E, Mele A, Craxì A, Almasio P. The aetiology of chronic hepatitis in Italy: results from a multicentre national study. Dig Liver Dis 2004; 36: 829-833 [PMID: 15646431 DOI: 10.1016/j.dld.2004.07.013]
69. Sagnelli E, Pasquale G, Coppola N, Marrocco C, Scarano F, Imparato M, Sagnelli C, Scolastico C, Piccinino F. Liver histology in patients with HBsAg negative anti-HBc and antiHCV positive chronic hepatitis. J Med Virol 2005; 75: 222-226 [PMID: 15602732 DOI: 10.1002/jmv.20260]
70. Stroffolini T, Sagnelli E, Almasio P, Ferrigno L, Craxì A, Mele A. Characteristics of liver cirrhosis in Italy: results from a multicenter national study. Dig Liver Dis 2004; 36: 56-60 [PMID: 14971816 DOI: 10.1016/j.dld.2003.07.007]
71. Sagnelli E, Stroffolini T, Mele A, Imparato M, Sagnelli C, Coppola N, Almasio PL. Impact of comorbidities on the severity of chronic hepatitis B at presentation. World J Gastroenterol 2012; 18: 1616-1621 [PMID: 22529690 DOI: 10.3748/ wjg.v18.i14.1616]
72. Fasano M, Saracino A, Carosi G, Mazzotta F, Marino N, Sagnelli E, Gaeta GB, Angarano G, Verucchi G, Bellissima P, Angeletti C, Santantonio T. Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study. Infection 2013; 41: 53-59 [PMID: 23264094 DOI: 10.1007/s15010-012-0384-9]
73. Rizzetto M. Hepatitis D: virology, clinical and epidemiological aspects. Acta Gastroenterol Belg 2000; 63: 221-224 [PMID: 10925472]
74. Kew MC. Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update. J Viral Hepat 2013; 20: 149-157 [PMID: 23383653 DOI: 10.1111/ jvh.12043]
75. Smedile A, Lavarini C, Farci P, Aricò S, Marinucci G, Dentico P, Giuliani G, Cargnel A, Del Vecchio Blanco C, Rizzetto M. Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy. Am J Epidemiol 1983; 117: 223-229 [PMID: 6829551]